ABSTRACT
Introduction
The incidence of thyroid nodules is 2-6% with clinical examination, 19-68% with ultrasound (US), and in autopsy specimens, it is 8-65%. [1, 2, 3] Thyroid nodules are 4 times more common in females than in males and more frequent in the iodine-deficient areas. Thyroid nodules' management has become increasingly a subject of debate with the increasing frequency of thyroid malignancies. Thyroid nodules can be (1) benign (Hashimoto's thyroiditis, subacute thyroiditis, colloid nodule, simple cyst, hemorrhagic cyst, and follicular adenoma) or (2) malignant (Papillary, Follicular, Medullary, Anaplastic, Hurthle Cell (oncocytic) carcinomas, thyroid lymphoma and metastases). [4, 5] Evaluation of a patient with a thyroid nodule should be initially started with a detailed history, clinical examination, Laboratory exams, and imaging studies. [6] Ultrasound is a noninvasive radiological technique that should be done in all patients with a thyroid disease to confirm the nodule/s, measure the size, site and assess the echogenicity, composition, shape, margins, vascularity, and the presence of calcification in the nodules as well as evaluate the other structures in the neck comprising the lymph nodes. [7, 8, 9] FNAC biopsy is the next step in the assessment of thyroid nodules. [10] According to the American Association of Clinical Endocrinologists guidelines, FNAC biopsy is "the most effective and accessible method for differentiating between malignant and benign thyroid lesions," with an accuracy around 95%. [11] In this study, we are trying to evaluate and compare the accuracy of both TI-RADS versus TBSRTC in the evaluation of thyroid nodules.
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Patients evaluated in the OPD through clinical, laboratory and radiological tools. Detailed medical history recorded, then patients examined generally plus local neck examination. Laboratory exams are done such as serumfree triiodothyronine (T3), free tetraiodothyronine (T4), thyroid-stimulating hormone (TSH), and Serum calcitonin. Diagnostic imaging was done by means of (1) radionuclide thyroid scan/scintigraphy, which was done in patients suffering from a thyroid nodule with low serum TSH to exclude the possibility of subclinical hyperthyroidism. (2) Thyroid US that was scored according to TIRADS classification as follows: (1) normal thyroid gland, (2) benign lesions, (3) probably benign lesions, (4) suspicious lesions, (5) probably malignant lesions, and (6) biopsy-proven malignancy. [12] The FNAC was implemented for all patients with a TIRADS > 2. Assessment of FNAC was done according to TBSRTC: class (I) non-diagnostic or unsatisfactory, (II) benign, (III) atypia of undetermined significance (AUS) or follicular lesion of undetermined significance (FLUS); (IV) follicular neoplasm or suspicious for a follicular neoplasm, (V) suspicious for malignancy, and (VI) malignant. [13] Before surgery, patients were admitted to the General Surgery Department and prepared for surgery, then operation done after signing a fully informed separate consent for the operation. Exclusion criteria were: patients with TI-RADS 1&2 and nodules less than 1 cm with no US feature suspicious for malignancy (no indication for FNAC or surgery), former thyroid or parathyroid operations, previous thyroid FNAC in the last 3 months (FNAC not recommended), unsatisfactory FNAC sample, age <18 years, patients' inability to offer informed consent.
Thyroid US Technique:
The Real-time B -mode US and Doppler assessment of the thyroid nodules was done by a radiologist with a good practice in thyroid US. The US scans were completed on GE VOLUSON 730 PRO machine (GE Healthcare, Milwaukee, USA) with a highfrequency linear array transducer . Images were inspected on the real-time two-dimensional grayscale and Doppler imaging. Patient placed in the supine position and hyper-extended neck. The neck was scanned in transverse, sagittal, and oblique sections to ideally see both thyroid lobes, isthmus. Also, the regions of the jugular veins and carotid arteries, as well as the supra-clavicular fossa, were visualized for any lymph node enlargement. The sonographic features in all saved images were examined; such as the internal composition, echogenicity, margins, presence of calcifications, and the shape of the nodule (Fig. 1) . For a patient with more than one thyroid nodule, classified as multinodular goiter (MNG) and the nodule with the most suspicious sonographic features was recorded as the nodule of interest. The internal structure of the nodule demarcated as cystic, solid, or mixed. The US parameters defined the suspicion of malignancy as follows: irregular border, micro-calcifications, hypo-echogenicity, and central flow by Doppler study. The nodule was defined as probably benign If it did not show suspicious features of malignancy.
The Technique of US-guided FNAC Biopsy: All procedures were performed by the pathologist and the radiologist, after obtaining a written informed consent, the patient was placed in the supine position with the hyper-extended neck. The skin and the 7.5-12 MHz linear transducer were cleansed with Betadine (povidone-iodine) solution. A sterile gel used as a coupling agent. The Initial US study was done to recognize the nodule of interest that indicated for FNAC according to the guidelines (Fig. 2) . Then, the Tyco Healthcare Monoject non-cutting bevelled edge needle (25-gauge, 5 cm in length) (Sherwood Medical, St. Louis, MO) was held in the right hand and the transducer in the left hand. The needle was connected to a 10 ml syringe, then it was entered through the skin at an oblique angle under US guidance, then it was moved through the centre of the nodule gently and rapidly with a mild suction. If the aspirated fluid contained much blood, a non-aspiration technique was applied, and the needle was moved in back and forth directions. A hematoma excluded through a post-procedure US.
Specimen Preparation and Interpretation:
By the pathologist, the aspirate was expelled over two clean slides (2 drops for each slide) and spread to form a film by a clean slide at 60° angle. Both slides were placed in ethanol 95% for fixation, then stained via the modified Papanicolaou procedure, and then submitted for evaluation and categorized into 1 of 6 categories according to the classification of the Bethesda system (Fig. 4) . [13] Surgery: Surgery was done for all patients included in our study. Patients with lesions suspicious of papillary or medullary thyroid cancer underwent a neck US + CT imaging to evaluate for any metastatic lesions. The US + CT imaging of the neck was done for patients with significant goiters, to rule out any retrosternal extension. Moreover, all patients underwent vocal cord function assessment and reported in the file before surgery. 
Results
The study included 100 patients; 22 males and 78 females with mean age 43.7 ± 11.5; range: 22-60 years. Nodules were in the right lobe of the thyroid gland in 40 patients, in the left lobe in 32 patients, in the isthmus in 2 patients, and in both lobs in 26 patients ( Table 1) . The mean operative time in our study 105±17.9; range: 55-150 minutes. Total thyroidectomy underwent for 48 patients, while hemithyroidectomy and near-total thyroidectomy were done for 37 and 15 patients respectively. The postoperative complications were minor with a transient hoarseness of voice and temporary hypoparathyroidism in 4 & 6 patients respectively ( Table 2) .
The Concordance Between TI-RADS and Bethesda System Categories: Fifty-five patients with thyroid nodules in our study were probably benign (TI-RADS 3), and FNA cytology established this result in 45/55 patients revealing an 82% concordance rate between US and FNAC. Among the 31 cases that were categorized as TI-RADS 4 (indeterminate), 8/31 cases were benign on FNAC (Bethesda II), 1/31 cases had a FNAC biopsy established as cancer, while the remaining 22/31 patients were fallen in Bethesda III, IV, and V giving a 70.9% concordance rate between the US and FNAC (see Fig. 3 ). Among the 14 cases that were categorized as TI-RADS 5 (malignant on the US), 2/14 patients were benign on FNAC biopsy (falsepositive impression of the US), 5/14 cases were suspicious on FNAC (Bethesda IV), and 7/14 cases had a FNAC biopsy established as cancer giving a 50% concordance between the US and FNAC. From the previous results, we can find that the overall concordance rate between US TI-RADS and Bethesda is 67.6% (Fig. 3 & 4) The Concordance of TI-RADS and Bethesda system for the final PO Histological Diagnosis: The overall concordance rate of US TI-RADS with the final PO Histological results for predicting malignancy for predicting malignancy was 75.4% with a sensitivity of 76.9 % and specificity 91.3%, PPV 71.4%, and NPV 76.4%. On the other hand, the overall concordance rate of FNAC with the final PO Histological findings for predicting malignancy was 95% with a sensitivity of 81.8% and specificity 98%, PPV 90%, and NPV 96%. (Table 3) summarizes the results and correlation. www.pacificejournals.com/apalm eISSN: 2349-6983; pISSN: 2394-6466 
Discussion
Evaluation of a thyroid nodule disease based on a process of four-step (Quadruple assessment) including; (1) detailed history, plus clinical examination, (2) laboratory exams involving thyroid function tests, (3) thyroid US, and (4) US-guided FNAC based on TI-RADS features. [14] It resembles the triple assessment of the breast lumps. However, TI-RADS US features are still not routinely used in several teaching institutes. [15] The accessibility of TI-RADS and recent validation of this US classification system by the ACR permits a precise clinical and pathological correlation. As noted from the preceding studies, [16, 17] a strong clinicopathological correlation will guide us in defining the risk of malignancy and hence direct our proper management of thyroid lesions. [18] In many countries around the world; surgeons, radiologists, and endocrinologists become aware of using the US classification system (TI-RADS) for evaluation of thyroid lesions and use it regularly in their clinical performance. [19] Depending on our own analysis of 100 cases of thyroid lesions, we have seen a fairly good concordance rate of both US TIRADS and FNAC biopsy for the final PO Histological results that was 75.4& 95%, respectively, which will be the baseline now for incoming quality upgrading as we become more conversant and experienced with the thyroid US. We have found from our experience in the outpatient clinic during the US evaluation of thyroid lesions that having a model of US pictures showing the variable TI-RADS categories are of benefit and help to diminish mistakes in recording the category of TI-RADS. Similar action is regularly used by endoscopists in the endoscopy unit for gastrointestinal lesions for example; grading of esophageal varices, reflux esophagitis, and bleeding gastric or duodenal ulcer.
When comparing our results with the outcomes of a study that was done by Singaporewalla et al, [20] the US impression of thyroid nodules in our study had a comparable sensitivity in predicting malignancy (71.5 % versus 70.6%) but lower specificity (85% versus 90.4%). We also had a comparable NPV of TI-RADS score predicting malignancy (91.5% versus 93.8%).
Regarding the overall accuracy, we had an accuracy of 75.3% compared with 83% in the previous mentioned study. On the other hand, on comparing our results with the data reported by Horvath et al, [7] our US had a lower sensitivity in predicting malignancy in thyroid nodules (71.5% compared to 88%) but higher specificity (85% compared to 49%). We also had a higher NPV of TIRADS score predicting malignancy as well (91.5% compared to 88%).
There is no doubt that, using the TI-RADS system for US reporting permits clinicians to improve their US skills and track their results in comparison with the FNAC findings. In Singaporewalla et al study, [20] they had 20 patients that were classified as TI-RADS 5 (malignant on the US), only 12 were confirmed as malignant with FNAC biopsy and the remaining were benign. This gives them a 60% accuracy of US in predicting malignancy. Similarly, in our study, we found that among the 14 cases that were categorized as TIRADS 5, 10/14 cases had a FNAC biopsy established as cancer (71.4% accuracy).
The limitations of this study are that we did not define the clinic-pathological correlation of TI-RADS subgroups 4a, 4b and 4c to the results of FNAC. Going forward, we hope to further sub-classify the TI-RADS 4 lesions into the different sub-categories and audit our results.
Several studies have verified the high global accuracy of FNAC biopsy for assessment of thyroid nodules, and this result has been established, mainly for patients with a solitary thyroid nodule and those with some US criteria of malignancy; however, FNAC biopsy has displayed less accuracy in the assessment of multinodular goiter. [21, 22, 23] The overall accuracy of FNAC biopsy in comparison with the final PO Histological reports in our study was 95% with sensitivity and specificity of 81.8% and 98%, respectively. In promise with these results, Krzysztof et al [24] reported that the rate of prediction of thyroid carcinoma by FNAC in the patients with a thyroid nodule was 95.8% and it was higher in patients with a solitary nodule than that in patients with multiple nodules (98% versus 96%, respectively) in the same study. [25] 
Conclusion
Our present study reveals a respectable clinic-pathological correlation between the thyroid US that was reported by the TI-RAD classification system and the FNAC results of thyroid nodule using Bethesda classification. For surgeons, the use of the TI-RAD system as a risk stratification for classifying thyroid lesions will be adopted from this time in our practice throughout US assessment of thyroid lesions.
Declarations
The Authors declare that there is no conflict of interest
